Literature DB >> 27604489

Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney.

Rohit Mehra1,2,3, Pankaj Vats1,3,4, Marcin Cieslik3, Xuhong Cao3,5, Fengyun Su3, Sudhanshu Shukla3, Aaron M Udager1, Rui Wang3, Jincheng Pan6, Katayoon Kasaian3, Robert Lonigro3, Javed Siddiqui3, Kumpati Premkumar4, Ganesh Palapattu7, Alon Weizer2,7, Khaled S Hafez7, J Stuart Wolf7, Ankur R Sangoi8, Kiril Trpkov9, Adeboye O Osunkoya10, Ming Zhou11, Giovanna Giannico12, Jesse K McKenney13, Saravana M Dhanasekaran1,3, Arul M Chinnaiyan14,2,3,5,7.   

Abstract

Mucinous tubular and spindle cell carcinoma (MTSCC) is a relatively rare subtype of renal cell carcinoma (RCC) with distinctive morphologic and cytogenetic features. Here, we carry out whole-exome and transcriptome sequencing of a multi-institutional cohort of MTSCC (n = 22). We demonstrate the presence of either biallelic loss of Hippo pathway tumor suppressor genes (TSG) and/or evidence of alteration of Hippo pathway genes in 85% of samples. PTPN14 (31%) and NF2 (22%) were the most commonly implicated Hippo pathway genes, whereas other genes such as SAV1 and HIPK2 were also involved in a mutually exclusive fashion. Mutations in the context of recurrent chromosomal losses amounted to biallelic alterations in these TSGs. As a readout of Hippo pathway inactivation, a majority of cases (90%) exhibited increased nuclear YAP1 protein expression. Taken together, nearly all cases of MTSCC exhibit some evidence of Hippo pathway dysregulation. SIGNIFICANCE: MTSCC is a rare and relatively recently described subtype of RCC. Next-generation sequencing of a multi-institutional MTSCC cohort revealed recurrent chromosomal losses and somatic mutations in the Hippo signaling pathway genes leading to potential YAP1 activation. In virtually all cases of MTSCC, there was evidence of Hippo pathway dysregulation, suggesting a common mechanistic basis for this disease. Cancer Discov; 6(11); 1258-66. ©2016 AACR.This article is highlighted in the In This Issue feature, p. 1197. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27604489      PMCID: PMC5096979          DOI: 10.1158/2159-8290.CD-16-0267

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  47 in total

1.  Hepatocyte nuclear factor 4 alpha is associated with mesenchymal-epithelial transition in developing kidneys of C57BL/6 mice.

Authors:  Tomonori Kanazawa; Osamu Ichii; Saori Otsuka; Yuka Namiki; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  J Vet Med Sci       Date:  2010-12-21       Impact factor: 1.267

2.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

3.  Human renal cell carcinogenesis is accompanied by a coordinate loss of the tissue specific transcription factors HNF4 alpha and HNF1 alpha.

Authors:  S Sel; T Ebert; G U Ryffel; T Drewes
Journal:  Cancer Lett       Date:  1996-03-29       Impact factor: 8.679

4.  Hippo pathway activity influences liver cell fate.

Authors:  Dean Yimlamai; Constantina Christodoulou; Giorgio G Galli; Kilangsungla Yanger; Brian Pepe-Mooney; Basanta Gurung; Kriti Shrestha; Patrick Cahan; Ben Z Stanger; Fernando D Camargo
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

Authors:  Amber L Couzens; James D R Knight; Michelle J Kean; Guoci Teo; Alexander Weiss; Wade H Dunham; Zhen-Yuan Lin; Richard D Bagshaw; Frank Sicheri; Tony Pawson; Jeffrey L Wrana; Hyungwon Choi; Anne-Claude Gingras
Journal:  Sci Signal       Date:  2013-11-19       Impact factor: 8.192

6.  Human genomics. The human transcriptome across tissues and individuals.

Authors:  Marta Melé; Pedro G Ferreira; Ferran Reverter; David S DeLuca; Jean Monlong; Michael Sammeth; Taylor R Young; Jakob M Goldmann; Dmitri D Pervouchine; Timothy J Sullivan; Rory Johnson; Ayellet V Segrè; Sarah Djebali; Anastasia Niarchou; Fred A Wright; Tuuli Lappalainen; Miquel Calvo; Gad Getz; Emmanouil T Dermitzakis; Kristin G Ardlie; Roderic Guigó
Journal:  Science       Date:  2015-05-08       Impact factor: 47.728

7.  Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.

Authors:  Zaidoun Salah; Gerry Melino; Rami I Aqeilan
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

8.  Of mice and men: divergence of gene expression patterns in kidney.

Authors:  Lydie Cheval; Fabien Pierrat; Rabary Rajerison; David Piquemal; Alain Doucet
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

9.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Nucleic Acids Res       Date:  2013-04-04       Impact factor: 16.971

10.  The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.

Authors:  Marcin Cieslik; Rashmi Chugh; Yi-Mi Wu; Ming Wu; Christine Brennan; Robert Lonigro; Fengyun Su; Rui Wang; Javed Siddiqui; Rohit Mehra; Xuhong Cao; David Lucas; Arul M Chinnaiyan; Dan Robinson
Journal:  Genome Res       Date:  2015-08-07       Impact factor: 9.043

View more
  22 in total

1.  SAV1 represses the development of human colorectal cancer by regulating the Akt-mTOR pathway in a YAP-dependent manner.

Authors:  Jianwu Jiang; Wei Chang; Yang Fu; Yongshun Gao; Chunlin Zhao; Xiefu Zhang; Shuijun Zhang
Journal:  Cell Prolif       Date:  2017-06-15       Impact factor: 6.831

2.  Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.

Authors:  Yasser Ged; Ying-Bei Chen; Andrea Knezevic; Mark T A Donoghue; Maria I Carlo; Chung-Han Lee; Darren R Feldman; Sujata Patil; A Ari Hakimi; Paul Russo; Martin H Voss; Robert J Motzer
Journal:  Clin Genitourin Cancer       Date:  2019-05-02       Impact factor: 2.872

Review 3.  Cancer transcriptome profiling at the juncture of clinical translation.

Authors:  Marcin Cieślik; Arul M Chinnaiyan
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

4.  Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.

Authors:  Stephanie L Skala; Hong Xiao; Aaron M Udager; Saravana M Dhanasekaran; Sudhanshu Shukla; Yang Zhang; Carrie Landau; Lina Shao; Diane Roulston; Lisha Wang; Javed Siddiqui; Xuhong Cao; Cristina Magi-Galluzzi; Miao Zhang; Adeboye O Osunkoya; Steven C Smith; Jesse K McKenney; Bryan L Betz; Jeffrey L Myers; Arul M Chinnaiyan; Scott A Tomlins; Rohit Mehra
Journal:  Mod Pathol       Date:  2017-08-25       Impact factor: 7.842

Review 5.  The tumor suppressor role of salvador family WW domain-containing protein 1 (SAV1): one of the key pieces of the tumor puzzle.

Authors:  Ísis Salviano Soares de Amorim; Mariana Moreno de Sousa Rodrigues; Andre Luiz Mencalha
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-12       Impact factor: 4.553

6.  YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.

Authors:  Shannon M White; Maria Laura Avantaggiati; Ivan Nemazanyy; Cristina Di Poto; Yang Yang; Mario Pende; Geoffrey T Gibney; Habtom W Ressom; Jeffery Field; Michael B Atkins; Chunling Yi
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

7.  VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.

Authors:  Lisha Wang; Yuping Zhang; Ying-Bei Chen; Stephanie L Skala; Hikmat A Al-Ahmadie; Xiaoming Wang; Xuhong Cao; Brendan A Veeneman; Jin Chen; Marcin Cieślik; Yuanyuan Qiao; Fengyun Su; Pankaj Vats; Javed Siddiqui; Hong Xiao; Evita T Sadimin; Jonathan I Epstein; Ming Zhou; Ankur R Sangoi; Kiril Trpkov; Adeboye O Osunkoya; Giovanna A Giannico; Jesse K McKenney; Pedram Argani; Satish K Tickoo; Victor E Reuter; Arul M Chinnaiyan; Saravana M Dhanasekaran; Rohit Mehra
Journal:  Am J Surg Pathol       Date:  2018-12       Impact factor: 6.394

Review 8.  The Hippo Signaling Pathway in Development and Disease.

Authors:  Yonggang Zheng; Duojia Pan
Journal:  Dev Cell       Date:  2019-08-05       Impact factor: 12.270

9.  A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer.

Authors:  Stephano S Mello; Liz J Valente; Nitin Raj; Jose A Seoane; Brittany M Flowers; Jacob McClendon; Kathryn T Bieging-Rolett; Jonghyeob Lee; Danton Ivanochko; Margaret M Kozak; Daniel T Chang; Teri A Longacre; Albert C Koong; Cheryl H Arrowsmith; Seung K Kim; Hannes Vogel; Laura D Wood; Ralph H Hruban; Christina Curtis; Laura D Attardi
Journal:  Cancer Cell       Date:  2017-10-09       Impact factor: 31.743

10.  Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.

Authors:  David J Clark; Saravana M Dhanasekaran; Francesca Petralia; Jianbo Pan; Xiaoyu Song; Yingwei Hu; Felipe da Veiga Leprevost; Boris Reva; Tung-Shing M Lih; Hui-Yin Chang; Weiping Ma; Chen Huang; Christopher J Ricketts; Lijun Chen; Azra Krek; Yize Li; Dmitry Rykunov; Qing Kay Li; Lin S Chen; Umut Ozbek; Suhas Vasaikar; Yige Wu; Seungyeul Yoo; Shrabanti Chowdhury; Matthew A Wyczalkowski; Jiayi Ji; Michael Schnaubelt; Andy Kong; Sunantha Sethuraman; Dmitry M Avtonomov; Minghui Ao; Antonio Colaprico; Song Cao; Kyung-Cho Cho; Selim Kalayci; Shiyong Ma; Wenke Liu; Kelly Ruggles; Anna Calinawan; Zeynep H Gümüş; Daniel Geiszler; Emily Kawaler; Guo Ci Teo; Bo Wen; Yuping Zhang; Sarah Keegan; Kai Li; Feng Chen; Nathan Edwards; Phillip M Pierorazio; Xi Steven Chen; Christian P Pavlovich; A Ari Hakimi; Gabriel Brominski; James J Hsieh; Andrzej Antczak; Tatiana Omelchenko; Jan Lubinski; Maciej Wiznerowicz; W Marston Linehan; Christopher R Kinsinger; Mathangi Thiagarajan; Emily S Boja; Mehdi Mesri; Tara Hiltke; Ana I Robles; Henry Rodriguez; Jiang Qian; David Fenyö; Bing Zhang; Li Ding; Eric Schadt; Arul M Chinnaiyan; Zhen Zhang; Gilbert S Omenn; Marcin Cieslik; Daniel W Chan; Alexey I Nesvizhskii; Pei Wang; Hui Zhang
Journal:  Cell       Date:  2019-10-31       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.